ArticleMolecular and clinical oncology2024
TPR is a prognostic biomarker and potential therapeutic target associated with immune infiltration in hepatocellular carcinoma.
Teng Long et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.